4. Serve Robotics Inc. (NASDAQ: SERV)
Hospital Robots Give the Business a Direct Healthcare Connection
Serve Robotics Inc. (NASDAQ: SERV) has a more direct medical-industry connection through its acquisition of Diligent Robotics, the developer of Moxi hospital robots. These machines assist healthcare teams with routine logistical tasks, including moving medications, laboratory samples, and supplies.
The distinction matters. Moxi supports the work surrounding patient care rather than diagnosing illnesses or delivering treatment. Its commercial proposition rests on reducing the time hospital employees spend transporting items, allowing staff to devote more attention to their primary responsibilities.
In August 2026, Diligent Robotics announced the rollout of Moxi 2.0, drawing on operating experience across more than 25 hospitals. The upgraded platform includes faster perception, revised sensors and storage, and improvements intended to help robots navigate busy clinical environments. Announced rollout locations included Children’s Hospital Los Angeles and other U.S. health systems.
This provides an established hospital automation application, although the scale and economics of future deployments still require scrutiny.
The Healthcare Opportunity Meets a Demanding Cost Structure
Serve Robotics Inc. (NASDAQ: SERV) reported second-quarter 2026 consolidated revenue of approximately $3.24 million and more than $240 million in cash and marketable securities at June 30.
However, management also lowered full-year revenue guidance to between $9 million and $10 million, citing weaker-than-expected delivery volumes through its Uber Eats partnership. Revised non-GAAP operating expense guidance remained substantial at $140 million to $150 million.
These are group-level figures, not a standalone measure of hospital robotics performance. The acquisition broadens the addressable market, but investors still need to assess whether hospital deployments can generate sufficient utilization and recurring revenue to justify installation, support, and development costs. A robot completing deliveries is useful; a fleet producing attractive economics is the larger business test.
Ranking Rationale
Serve Robotics Inc. (NASDAQ: SERV) retains No. 4 because it combines an operating hospital robotics platform with substantial financial resources. Its healthcare exposure is more concrete than a proposed product strategy, while reduced consolidated guidance and a large expense base continue to constrain the investment case.
